The FACS analysis revealed an increase in the percentage of CD4+ (2.99 ± 0.15) and CD8+ (1.82 ± 0.13) T cells in the bone marrow of glioma-bearing mice when compared to untreated glioma-free mice (controls). The gene discussed is CD8A; the disease is central nervous system cancer.